Colombia has new diagnostic algorithm for the Chagas Disease Implementation Pilot Projects
Colombia has new diagnostic algorithm for the Chagas Disease Implementation Pilot Projects
[November 2016] The implementation Project for Chagas disease in Colombia is moving forward. After an epidemiological analysis, the partners confirmed the change of the diagnostic algorithm for the country's pilot projects. With the new algorithm, positive cases for Chagas are confirmed by a simpler procedure test.
Colombia has new diagnostic algorithm for the Chagas Disease Implementation Pilot Projects
“Towards Ending the Neglect?” DNDi releases update on its Paediatric HIV Programme
“Towards Ending the Neglect?” DNDi releases update on its Paediatric HIV Programme
[July 2016] As the International AIDS Conference kicks off in Durban, the Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing “4-in-1” fixed-dose combinations using the World Health Organization (WHO) recommended treat­ment regimen for infants and young chil­dren. DNDi’s update also discusses some promising developments for treatment for children living with both HIV and tuberculosis (TB).
“Towards Ending the Neglect?” DNDi releases update on its Paediatric HIV Programme
The global response to AMR must not fail to address the needs of neglected patients
The global response to AMR must not fail to address the needs of neglected patients
Manica BalasegaramManica Balasegaram, Director, Global Antiobiotic Research and Development Partnership [June 2016] Far from being an apocalyptic fantasy, a post-antibiotic era in which common infections and minor injuries can kill has become a very real possibility. Of late, media headlines about ‘the end of the road’ for antibiotics have been plentiful. The latest case in May this year to receive a good deal of attention was of a patient in the US found to be carrying bacteria resistant to antibiotics of last resort. [Español] [Português]
The global response to AMR must not fail to address the needs of neglected patients
AusTrade supports Epichem leishmaniasis research programme
AusTrade supports Epichem leishmaniasis research programme
DNDi and its partner Epichem are pleased to announce that the Australian Tropical Medicine Commercialisation Grants Programme (ATMCG), with the support of Australia’s Trade and Investment Ministry (AusTrade), are providing $250,000 for a project which is focused on developing new treatments for leishmaniasis. The name of the project is: “Novel compounds for the treatment of Leishmaniasis in humans and animals,” which will be led by PharmAust Limited’s (ASX:PAA) subsidiary Epichem in partnership with DNDi.
AusTrade supports Epichem leishmaniasis research programme
See all news

Scientific Articles

See all scientific articles

Events

  • 10º ENIFarMed

    Encontro Nacional da Inovação em Fármacos e Medicamentos

    October 17-18, 2016 São Paulo, Brazil DNDi Latin America presented on Lead Optimization in Latin America and hepatitis C.
  • ASTMH 2016

    American Society of Tropical Medicine and Hygiene (ASTMH), 65th Annual Meeting

    November 13-17, 2016 Atlanta, Georgia USA DNDi presented in symposia on sleeping sickness and Chagas disease, they also co-authored poster presentations on filarial diseases.
  • WorldLeish 6

    6th World Congress on Leishmaniasis

    May 16-20, 2017 Toledo, Spain The WHO ColIaborating Centre for Leishmaniasis at the Instituto de Salud Carlos III, Madrid and the Drugs for Neglected Diseases initiative, Geneva have joined efforts to co-organize the WorldLeish-6 Congress.
See all events